New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 29, 2014
07:06 EDTINSYInsys Therapeutics submits Type II DMF to FDA for CBD API
Insys Therapeutics announced it has submitted a Type II Drug Master File, or DMF, to the FDA for its cannabidiol, or CBD, active pharmaceutical ingredient, or API, and has been issued DMF# 28255. Insys recently announced plans to advance development of its pharmaceutical CBD program for the treatment of epilepsy in children and adults.
News For INSY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 24, 2015
15:09 EDTINSYInsys falls after SIRF links drug to 'growing number' of deaths
Subscribe for More Information
April 23, 2015
07:17 EDTINSYInsys Therapeutics commences dosing in Phase 1/2 study of CBD oral solution
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use